Molina Healthcare, Inc. (MOH) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$197.44
Price Target
$166.09
Target Range
$124.00 — $224.00
Analyst Rating
Buy
Forward P/E38.3x
Trailing P/E22.1x
Forward PEG—
Implied Growth+39.9%
Median Target$160.00
Analyst Spread60.2%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$124
-37.2%
Consensus
$166
-15.9%
Bull Case
$224
+13.5%
MOH Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Molina Healthcare, Inc. (MOH) has a Wall Street consensus price target of $166.09, based on estimates from 38 covering analysts. With the stock currently trading at $197.44, this represents a potential downside of -15.9%. The company has a market capitalization of $10.28B.
Analyst price targets range from a low of $124.00 to a high of $224.00, representing a 60% spread in expectations. The median target of $160.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 17 analysts rating the stock as a Buy or Strong Buy,15 rating it Hold, and 6 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, MOH trades at a trailing P/E of 22.1x and forward P/E of 38.3x. Analysts expect EPS to grow +39.9% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+11.2%
Avg Forward P/E31.0x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CNCCentene Corporation | $27.3B | $55.31 | $51.00 | -7.8% | Buy | 16.4x | 43 |
 ALHCAlignment Healthcare, Inc. | $3.7B | $18.14 | $24.83 | +36.9% | Buy | 140.1x | 16 |
 UNHUnitedHealth Group Incorporated | $333.4B | $367.28 | $385.43 | +4.9% | Buy | 20.1x | 52 |
 CVSCVS Health Corporation | $111.3B | $86.86 | $95.20 | +9.6% | Buy | 12.1x | 41 |
 ELVElevance Health Inc. | $81.4B | $374.71 | $382.38 | +2.0% | Buy | 14.0x | 37 |
 HUMHumana Inc. | $29.6B | $246.33 | $246.00 | -0.1% | Hold | 27.6x | 44 |
 CICigna Corporation | $74.3B | $281.98 | $328.00 | +16.3% | Buy | 9.3x | 39 |
 OSCROscar Health, Inc. | $5.1B | $19.84 | $16.75 | -15.6% | Hold | 32.9x | 11 |
 MCKMcKesson Corporation | $91.1B | $743.67 | $1006.50 | +35.3% | Buy | 19.1x | 31 |
 CAHCardinal Health, Inc. | $45.1B | $191.49 | $249.67 | +30.4% | Buy | 18.5x | 33 |
Upside Potential Comparison
ALHCMCKCAHCICVSUNHELVHUMFull MOH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See MOH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MOH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MOH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMOH — Frequently Asked Questions
Quick answers to the most common questions about buying MOH stock.
What is the MOH stock price target for 2026?
MOH's consensus price target is $166.09, -15.9% below the current price of $197.44. The 38 analysts tracking MOH see downside risk at present valuations.
Is MOH a buy, sell, or hold?
MOH has a consensus rating of "Buy" based on 38 Wall Street analysts. The rating breakdown is mixed, with 15 Hold ratings making up the largest segment. The consensus 12-month price target of $166.09 implies -15.9% downside from current levels.
Is MOH stock overvalued or undervalued?
At a forward P/E of 38.2947x, MOH trades at a premium valuation. The consensus price target of $166.09 (-15.9% downside) suggests analysts may view current valuations as stretched.
How high can MOH stock go?
The most bullish Wall Street analyst has a price target of $224 for MOH, while the most conservative target is $124. The consensus of $166.09 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover MOH stock?
MOH is heavily covered by Wall Street, with 38 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 17 have Buy ratings, 15 recommend Hold, and 6 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the MOH stock forecast?
The 12-month MOH stock forecast based on 38 Wall Street analysts shows a consensus price target of $166.09, with estimates ranging from $124 (bear case) to $224 (bull case). The median consensus rating is "Buy".
What is MOH's forward P/E ratio?
MOH trades at a forward P/E ratio of 38.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.1x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy MOH stock?
Analysts are cautious on MOH, with 6 Sell ratings and a price target of $166.09 (-15.9% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do MOH price targets vary so much?
MOH analyst price targets range from $124 to $224, a 60% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $166.09 consensus represents the middle ground.